Phenyltoloxamine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H21NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K65LB6598J, chemically known as n,n-dimethyl-2-(alpha-phenyl-o-tolyloxy)ethylamine but generally known as phenyltoloxamine, which bears US NIH Compound Identifier 7077. European Medicines Agency schedules Phenyltoloxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09791MIG. The term PHENYLTOLOXAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). PHENYLTOLOXAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phenyltoloxamine under HS 29221980 and SITC 51461. As of Q4 2014, PHENYLTOLOXAMINE remains the US FDA Preferred Term for this commodity. Phenyltoloxamine bears US NLM identifiers UMLS ID C0070709 and NCI Concept Code C47669. SMILES: O(C1C(CC2CCCCC2)CCCC1)CCN(C)C.